ART MEDICAL
ART MEDICAL is an Israeli medical device company that develops the smART+ Platform — sensor-based enteral feeding tubes with proprietary AI algorithms for ICU patients — to prevent aspiration pneumonia, malnutrition, and related complications in hospitals.
- Company typePrivate
- Founded2008
- HeadquartersNetanya, Israel
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What ART MEDICAL does
ART MEDICAL is a Netanya, Israel-based medical device company founded in 2008 that develops the smART+ Platform, a sensor-based enteral feeding tube system designed for critically ill patients in intensive care units. The platform combines proprietary hardware — smart feeding tubes with embedded sensors — with proprietary software and AI-driven algorithms to automate and monitor enteral nutrition, detect complications such as aspiration and reflux, verify tube positioning, and calculate resting energy expenditure. The system is sold as an integrated stack comprising a Console, Hub, Cart, and disposable ARR (feeding) Set, and the company holds approximately 160 granted patents protecting its sensor and algorithm intellectual property.
The company targets hospital ICUs as its primary customer segment, with the stated clinical goal of preventing aspiration pneumonia, malnutrition, and acute kidney injury. ART MEDICAL distributes through a Teva Israel distribution partnership established in March 2023 and through direct enterprise sales to hospitals. Reference accounts disclosed include Rabin Medical Center, Herzliya Medical Center, and Thomas Jefferson University. The flagship smART V1 system holds CE Mark and AMAR (Israeli Ministry of Health) clearance but is not yet approved for sale in the United States.
ART MEDICAL has raised approximately $60 million across five funding rounds between 2012 and 2024, with the most recent — a $20.5 million round in August 2024 — being the largest. The company employs roughly 80 people, of which approximately 78% are allocated to R&D. The senior technical team includes a CTO who co-founded Given Imaging (the Israeli medtech pioneer of video capsule endoscopy) and a CMO who participated in Given Imaging's capsule development.
ART MEDICAL firmographics
Firmographics- Name
- ART MEDICAL
- Legal name
- ART MEDICAL Ltd.
- Website
- https://artmedical.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- ART MEDICAL is an Israeli medical device company that develops the smART+ Platform — sensor-based enteral feeding tubes with proprietary AI algorithms for ICU patients — to prevent aspiration pneumonia, malnutrition, and related complications in hospitals.
- Ownership category
- akta.pro rank
ART MEDICAL industry classification
Industry- Product category
- ICU Critical Care Nutrition Management Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)
- akta.pro secondary industry
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)
Keywords
Where ART MEDICAL is headquartered
LocationHeadquarters
- HQ city
- Netanya
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
ART MEDICAL business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales (Hardware + Software Platform): ART MEDICAL generates revenue through the sale of its smART+ Platform, which includes sensor-based feeding tubes, smart disposables, and accompanying software. The system is sold to hospitals and ICUs as a comprehensive critical care nutrition management solution. Pricing is not publicly disclosed and likely involves direct enterprise sales negotiations with hospital procurement departments.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels9 records
ART MEDICAL product offering
Product offeringCore offering
ART MEDICAL develops and sells the smART+ Platform, an integrated critical care nutrition management system for ICU patients. The platform combines sensor-based enteral feeding tubes, proprietary software, and AI-driven algorithms to automatically detect reflux, monitor tube position, calculate resting energy expenditure, drain gastric residual volume, compensate for feeding interruptions, and predict acute kidney injury via continuous urine flow monitoring. The system is sold to hospitals and intensive care units as a complete hardware-plus-software solution aimed at preventing aspiration pneumonia, malnutrition, ventilator-associated events, and AKI in mechanically ventilated patients.
Product overview
ART MEDICAL offers the smART+ Platform as its primary offering, a comprehensive critical care nutrition management ecosystem that combines sensor-based feeding tubes, software, and algorithms. The platform includes multiple integrated components: the Console (control center), Hub (for continuous REE calculation), Cart (for reflux detection), specialized Feeding Tubes with embedded sensors, Fluid Bags with ENfit connectors, and the ARR Set for urine monitoring. The company also previously offered the smART V1 System (first generation), which is no longer approved for US sales. The smART+ Platform represents an all-in-one solution designed to detect and prevent ICU-acquired complications including aspiration pneumonia, malnutrition, ventilator-associated events, and acute kidney injury through real-time monitoring, automated responses, and nutrition optimization.
Differentiator
Problem solved
Functional benefit
Brands
- smART+ Platform: A comprehensive solution for critical care nutrition management featuring sensor-based feeding tubes, software, and algorithms designed to reduce ICU-acquired complications such as malnutrition and aspiration.
- smART V1 System
Products and services
- smART+ Platform Comprehensive critical care nutrition management platform for hospitals and ICUs, combining a sensor-based enteral feeding tube, proprietary software, and AI-driven algorithms. Detects reflux in real time, automatically halts feeding during reflux, drains gastric residual volume via passive flow, calculates resting energy expenditure (REE), compensates for missed nutrition, monitors tube position, and tracks urine output for early acute kidney injury detection. Designed for mechanically ventilated adult ICU patients to prevent aspiration pneumonia, malnutrition, ventilator-associated events, and AKI. CE Mark and AMAR cleared.
- smART V1 System First-generation enteral feeding system for clinical settings, incorporating the smART V1 feeding pump, smART V1 feeding tube with sensors for tube tip location monitoring relative to the lower esophageal sphincter (LES), and accessory sets and bags. Intended for adult patients physically unable to eat and swallow, used by professional users in clinical settings. Automatically stops feeding and alerts clinical staff in real time when the tube migrates out of position or when reflux is detected. NOT approved for sales in the US.
Quantifiable outcome
- 89.5% feeding efficiency vs. 65.7% control (p<0.0001) in randomized clinical trial
- +4 more outcomes
Companies that use ART MEDICAL
Customer profileNamed customers3 records
Segments1 record
Ideal customer profiles1 record
ART MEDICAL technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature7 records
ART MEDICAL partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Teva IsraelcoreART MEDICAL announced a partnership with Teva Israel in March 2023, under which Teva Israel markets and distributes ART MEDICAL's smART+ Platform in Israel's intensive care units. Teva Israel serves as the exclusive or primary distributor for the Israeli market, leveraging its established healthcare distribution network.
- Israel Innovation Authority and Thomas Jefferson UniversitycoreART MEDICAL was selected as a winner of the Jefferson-Israel $1M innovation competition jointly run by Thomas Jefferson University (Philadelphia) and the Israel Innovation Authority. The program enables Israeli startups to develop, test, and pilot technologies at Thomas Jefferson University hospitals. The company is also a recipient of the Israel Innovation Authority–Thomas Jefferson University Hospitals grant.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
ART MEDICAL competitors and assessment
Company assessmentDirect peers
- Avanos Medical: Avanos Medical (formerly Halyard Health) is a medical device company with a significant enteral feeding product portfolio (MIC-KEY feeding tubes, Kangaroo enteral pumps). Directly comparable as it serves the same hospital ICU customer base with enteral nutrition delivery devices.
- B. Braun Melsungen: B. Braun is a global medical device company with a strong enteral nutrition pump and consumables portfolio (Infusomat, Enteralite). Directly comparable as it sells sensor-equipped and conventional enteral feeding systems to hospitals and ICUs worldwide.
- Cardinal Health: Cardinal Health distributes enteral feeding pumps, tubes, and nutritional products to US hospitals through its medical segment. Directly comparable as a major channel for ICU enteral nutrition devices and consumables.
- Vygon: Vygon is a French medical device specialist with a dedicated enteral nutrition product line (Nutrisafe, gastrostomy tubes). Directly comparable as it focuses on hospital enteral feeding devices for neonatal and adult ICU populations.
- Fresenius Kabi: Fresenius Kabi is a major player in clinical nutrition, offering enteral feeding pumps (APPLIX), feeding tubes, and enteral formula. Directly comparable as it serves ICU nutrition needs across both the pump/hardware and consumables layer.
Broad incumbents
- Medtronic: Medtronic acquired Given Imaging (co-founded by ART MEDICAL CTO Gabi Iddan) and operates broadly across patient monitoring, GI, and critical care. Comparable as a broad incumbent in connected GI and ICU-adjacent medical devices, though not specialized in enteral nutrition specifically.
- Abbott Nutrition: Abbott's Nutrition division supplies enteral formulas (Ensure, Jevity) used in ICU feeding protocols. Comparable as an incumbent that touches ICU nutrition, though its focus is on formula rather than delivery devices.
- ICU Medical: ICU Medical is a US-listed medical device company specializing in IV therapy and critical care devices. Comparable as an incumbent serving the ICU market with consumables-driven revenue, overlapping in customer base and procurement dynamics.
- Baxter International: Baxter offers nutrition and IV therapy products for ICU patients, including enteral feeding pumps and clinical nutrition solutions. Comparable as a broad incumbent in hospital nutrition and critical care delivery.
Emerging players
- Masimo: Masimo is a connected patient monitoring company known for pulse oximetry and ICU monitoring sensors. Comparable as it is expanding into sensor-based, AI-driven critical care monitoring that intersects with ART MEDICAL's connected-device ICU proposition.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
ART MEDICAL social profiles
Digital presenceART MEDICAL compliance and trust
Trust signalCompliance3 records
ART MEDICAL financial estimates
Financial estimateRevenue estimate
Valuation estimate
ART MEDICAL leadership team
Management profileNumber of profiles
Profiles11 records
ART MEDICAL funding detail
Funding detailFunding overview
Funding rounds5 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ART MEDICAL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ART MEDICAL
What does ART MEDICAL do?
ART MEDICAL develops and sells the smART+ Platform, an integrated critical care nutrition management system for ICU patients. The platform combines sensor-based enteral feeding tubes, proprietary software, and AI-driven algorithms to automatically detect reflux, monitor tube position, calculate resting energy expenditure, drain gastric residual volume, compensate for feeding interruptions, and predict acute kidney injury via continuous urine flow monitoring. The system is sold to hospitals and intensive care units as a complete hardware-plus-software solution aimed at preventing aspiration pneumonia, malnutrition, ventilator-associated events, and AKI in mechanically ventilated patients.
Is ART MEDICAL a public or private company?
ART MEDICAL is a private company. It is classified as venture growth investor backed and is currently operating.
When was ART MEDICAL founded?
ART MEDICAL was founded in 2008. It employs 51 to 100 people.
Where is ART MEDICAL based?
ART MEDICAL is headquartered in Netanya, Israel, in the Middle East region.
How does ART MEDICAL make money?
One revenue line is on record: medical Device Sales (Hardware + Software Platform).
Who are ART MEDICAL's main competitors?
Direct peers on record are Avanos Medical, B. Braun Melsungen, Cardinal Health, Vygon and Fresenius Kabi. Broad incumbents are Medtronic, Abbott Nutrition, ICU Medical and Baxter International. Masimo is listed as an emerging player.
Does ART MEDICAL have an API?
No public API is recorded for ART MEDICAL.
What industry is ART MEDICAL in?
ART MEDICAL's product category is ICU Critical Care Nutrition Management Medical Devices. Its primary akta.pro industry code is HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring, with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3841.